TSW
TLSI icon

Thompson Siegel & Walmsley’s TriSalus Life Sciences TLSI Stock Holding History

Thompson Siegel & Walmsley’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33M Buy
+583,574
New +$2.86M 0.04% 275

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Thompson Siegel & Walmsley's TLSI Position: Q1 2026 in Review

Thompson Siegel & Walmsley opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 583,574 shares worth $2.33M. The stake represents 0.04% of the portfolio and ranks #275 among its holdings.

84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Thompson Siegel & Walmsley held 583,574 shares of TriSalus Life Sciences worth $2.33M as of Q1 2026.
  • TriSalus Life Sciences was a new Thompson Siegel & Walmsley position in Q1 2026.
  • TriSalus Life Sciences made up 0.04% of Thompson Siegel & Walmsley's portfolio in Q1 2026, its #275 holding.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2026, filed 11 May 2026.